New York HMOs beat US average on quality

2 July 2001

Health maintenance organizations operating in New York state currentlyreceive high ratings on access and service from 60% of their members, down from 62% in 2000, although this compares with a national average of 57%, according to an annual survey conducted by the New York State Health Accountability Foundation.

The New York HMOs scored particularly well this year in their treatment of heart attack victims, with 87% of members hospitalized for this indication being treated with beta blockers, up from 74% in 2000 and compared with a national average of 85%. However, in New York, only 53% of asthma patients received medications recommended by the National Heart, Lung and Blood Institute, compared with a nationwide average of 57%.

In addition, most plans in New York were found to be implementing programs for the training of physicians and patients on the use of long-term medication for asthma, and the majority have also introduced disease management programs for asthma.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight